Generating mechanism and treatment of parkinsonian symptoms
Narabayashi, H.
Rinsho Shinkeigaku 22(12): 1055-1062
1982
ISSN/ISBN: 0009-918X PMID: 7168940 Document Number: 186213
Document emailed within 1 workday
Related Documents
McMeekin, H. 2007: Treatment of bipolar disorder, restless legs syndrome and parkinsonian symptoms using lamotrigine: a report of seven patients Journal of the South Carolina Medical Association 103(3): 69-73Cabo-López, I.; García-Bermejo, P.; García-Ruiz, P.J. 2007: Levodopa withdrawal symptoms in a non-Parkinsonian patient Revista de Neurologia 45(3): 190
Myslobodsky, M.S.; Holden, T.; Sandler, R. 1986: Parkinsonian symptoms in tardive dyskinesia. A prevalence study South African Medical Journal 69(7): 424-426
Miyashita, N.; Narabayashi, H. 2000: Clinical pathophysiology of parkinsonian symptoms: from experiences of stereotaxic surgery Nihon Rinsho. Japanese Journal of Clinical Medicine 58(10): 1980-1986
Kanegasaki, S. 1993: Superoxide-generating system in leukocytes: its activation mechanism and significance Human Cell 6(4): 245-252
Ransmayr, G.; Künig, G.; Neubauer, M.; Wagner, M.; Bösch, S.; Kreczy-Kleedorfer, B. 1993: Is the decreasing responsiveness of axial motor symptoms to L-dopa in elderly parkinsonian patients related to age-associated nonparkinsonian pathologies? Advances in Neurology 60: 685-689
Sigwald, J. 1974: Clinical evaluation of the parkinsonian state. Method of evaluation, with a punch-card system, of the gravity of signs and symptoms and of the degree of impairment of various types of activity La Clinica Terapeutica 70(6): 507-530
English, D.; Schell, M.; Siakotos, A.; Gabig, T.G. 1986: Reversible activation of the neutrophil superoxide generating system by hexachlorocyclohexane: correlation with effects on a subcellular superoxide-generating fraction Journal of Immunology 137(1): 283-290
Khan, N.S.; Shaheed, F.; Mitha, Y.; Rehman, S. 1985: Initiatives for improving the employment conditions of rural women: the cases of Shah Kot training and income-generating and the Sungli income generating projects for women, Pakistan Rural development and women: lessons from the field, Volume I: 117-136
Khan, N.S.; Shaheed, F.; Mitha, Y.; Rehman, S. 1985: Initiatives for improving the employment conditions of rural women: the cases of Shah Kot training and income-generating and the Sungli income generating projects for women, Pakistan Rural development and women: lessons from the field, Volume I: 117-136
Piccirilli, M.; D'Alessandro, P.; Testa, A.; Piccinin, G.L.; Agostini, L. 1985: Bornaprine in the treatment of parkinsonian tremor Rivista di Neurologia 55(1): 38-45
Yokochi, F. 2000: Pharmacological treatment of parkinsonian tremor Nihon Rinsho. Japanese Journal of Clinical Medicine 58(10): 2091-2095
Martínez-Lage, J.M.; Marti-Massó, J.F.; Delgado, G.; Carreray, N.; Del Amo, F. 1974: A year of treatment with carbidopa and levodopa in Parkinsonian patients Revista Clinica Espanola 134(6): 535-542
Kadykov, A.S. 1976: The effectiveness of amantadine (midantan) in the treatment of the parkinsonian syndrome Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 76(2): 174-178
Tardieu, S.; Becker, H.; Micallef, J.; Blin, O. 2003: Treatment of non-dopamine-dependent signs in parkinsonian syndromes: evaluation and results Revue Neurologique (Paris) 159(5 Part 2): 3s87-3s92
Obeid-Ruggli, V.; Probst, G. 1971: Clinical treatment of symptoms of veinous insufficiency symptoms with Sandoven Schweizerische Rundschau für Medizin Praxis 60(37): 1247-1250
Melamed, E. 1995: Does treatment with dopamine agonists affect utilization of exogenous levodopa in the parkinsonian striatum? Journal of Neural Transmission. Supplementum 45: 57-60
2005: Dual mechanism of action. Remission of physical symptoms MMW Fortschritte der Medizin 147 Spec No 2: 87
Bergonzi, P.; Chiurulla, C.; Tempesta, E. 1971: Organization of nocturnal sleep in parkinsonian patients: modifications of the phases and cycles in the course of pharmacological treatment Rivista di Neurologia 41(5): 326-334
Shan, D.E.; Yeh, S.I. 1996: An add-on study of selegiline to Madopar in the treatment of parkinsonian patients with dose-related fluctuations: comparison between Jumexal and Parkryl Zhonghua Yi Xue Za Zhi 58(4): 264-268